Cellectar Biosciences to Present at the 28th Annual Roth Capital Conference
MADISON, Wis., March 08, 2016 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (NASDAQ:CLRB), an oncology-focused biotechnology company, announces today its CEO, Jim Caruso, will be presenting at the 28th Annual Roth Capital Conference at the Ritz-Carlton …